Cases & Deals

Dendreon completes $229.9 million public offering of Common Stock

Clients Dendreon Corporation

Jones Day advised Dendreon Corporation, a biotechnology company focused on the discovery, development and commercialization of therapeutics that improve cancer treatment options for patients, in connection with the $229.9 million public offering of Common Stock, underwritten by Deutsche Bank Securities.